Profound Medical Corp (PROF) Stock Price, Quote & News

Company Profile

Profound Medical Corp. operates as a commercial-stage medical device company that develops and markets AI-powered, MRI-guided, incision-free therapeutic systems for the image guided ablation of diseased tissue. The company's lead product TULSA-PRO system combines magnetic resonance imaging (MRI), robotically driven transurethral sweeping action/thermal ultrasound and closed-loop temperature feedback control to ablate whole gland or physician defined region of malignant or benign prostate tissue....

Industry: Medical Devices

Sector: Healthcare

Phone: 647 476 1350

Fax: 647 847 3739

Website: www.profoundmedical.com

Address:

2400 Skymark Avenue, Unit 6, Mississauga, Canada

BioTuesdays May. 28 at 1:49 PM

Closely held AiM Medical Robotics has announced a collaboration agreement with Siemens Healthineers for the implementation of an interface enabling AiM’s robotic platform to operate with MRI systems from Siemens Healthineers $PROF https://biotuesdays.com/2026/05/27/the-imri-revolution-gets-another-boost-from-aims-collaboration-with-siemens-to-advance-robotic-neurosurgery/

0 · Reply

alexpitti May. 27 at 1:38 AM

med tech is historically cheap $SI $STXS $PROF $DCTH

0 · Reply

Doozio May. 21 at 1:22 AM

Chop chop huckleberries $PROF Then ONTO 🐒🍌🧠⏰♾️

1 · Reply

NVDAMillionaire May. 19 at 9:29 PM

$PROF Great piece that accurately captures PROF's current position. So if you want to refresh your understanding of PROF or learn about PROF for the first time, this is essential reading. https://everyticker.com/quote/PROF/analysis/profound-medical-s-reimbursement-inflection-meets-mri-guided-precision-a-platform-in-the-making-nasdaq-prof

0 · Reply

BioTuesdays May. 15 at 3:15 PM

$TLX announced that it has entered into letters of intent to pursue collaborations to explore the investigational use of its PSMA-PET imaging agents Gozellix (kit for the preparation of gallium Ga 68 gozetotide) and Illuccix (kit for the preparation of gallium Ga 68 gozetotide) with high-intensity focused ultrasound (HIFU) for focal prostate cancer ablation and Profound Medical’s $PROF MRI-guided transurethral ultrasound (TULSA) procedure for whole-gland, subtotal, and focal prostate cancer ablation. https://biotuesdays.com/2026/05/15/telix-in-psma-collaboration-with-profound-medical-and-other-prostate-cancer-therapy-players/

0 · Reply

CHItraders May. 15 at 11:35 AM

TELIX INKS LOI TO PAIR PSMA-PET WITH HIFU ROBOTICS FOR PROSTATE CA $TLX entered letters of intent with $EDAP and $PROF to explore combining its Gozellix and Illuccix PSMA-PET imaging agents with robotic HIFU and other image-guided therapies for localized prostate cancer. 🔹 Focus on patient selection, treatment planning, and post-treatment monitoring 🔹 Goal: better outcomes with less collateral damage (incontinence, impotence) 🔹 Non-promotional scientific and research collaboration push

1 · Reply

alexpitti May. 14 at 4:03 PM

$PROF met with ceo again! arun is a great guy

1 · Reply

newsfile_corp May. 14 at 12:42 AM

https://nfne.ws/297432 $PROF $PRN.TSX @profound-medical-inc #Chemicals #Pharmaceutical #HealthCare #Medical #Pharmaceuticals #AGM #AnnualGe

0 · Reply

OfficialStocktwitsUser May. 13 at 4:59 AM

$PROF RSI: 54.48, MACD: 0.1930 Vol: 0.25, MA20: 6.87, MA50: 6.36 🔴 SELL - Downtrend 👉 https://quantumstockalerts.com Disclaimer: I am not a financial advisor. This post reflects personal analysis and opinions only. Please do your own research before investing or trading.

0 · Reply

MarketBeat May. 8 at 9:09 PM

Profound Medical Q1 Earnings Call Highlights $PROF https://www.marketbeat.com/instant-alerts/profound-medical-q1-earnings-call-highlights-2

0 · Reply

Telix announces LoI to collaborate with EDAP TMS and Profound Medical

EDAP

Thu, 14 May 2026 07:00:00 -0400 - 18 days ago

Profound to Showcase TULSA-PRO®, the TULSA Procedure™ and the Future of iMRI at AUA2026

Wed, 13 May 2026 20:40:58 -0400 - 18 days ago

Profound Medical Annual General and Special Meeting of Shareholders Voting Results

2026-05-13T22:01:26.000Z - 18 days ago

Profound Medical Corp Annual Shareholders Meeting Transcript

2026-05-12T22:27:09.000Z - 19 days ago

Profound Medical files to sell 921,428 common shares for holders

May 12, 2026, 8:00 AM EDT - 20 days ago

Profound Medical Registration statement: Registration filing

Fri, 08 May 2026 17:09:15 -0400 - 23 days ago

Profound Medical Q1 Earnings Call Highlights

2026-05-08T12:46:30.000Z - 24 days ago

Profound Medical price target lowered to $10 from $12 at Stifel

May 7, 2026, 4:30 PM EDT - 24 days ago

Profound Medical Earnings Call Transcript: Q1 2026

May 7, 2026, 4:30 PM EDT - 24 days ago

Profound Medical Earnings release: Q1 2026

May 7, 2026, 4:30 PM EDT - 24 days ago

Profound Medical Quarterly report: Q1 2026

Thu, 07 May 2026 16:05:00 -0400 - 24 days ago

Profound Medical Reports Strong First Quarter 2026 Financial Results

May 7, 2026, 7:00 AM EDT - 25 days ago

Profound Medical Slides: Corporate presentation

2026-05-06T13:33:03.000Z - 26 days ago

Profound Medical Corp (PROF) Q1 2026 Earnings Report Preview: What to Expect

Apr 22, 2026, 10:00 AM EDT - 5 weeks ago

Profound Medical Transcript: 2026 Bloom Burton & Co. Healthcare Investor Conference

Tue, 21 Apr 2026 16:51:00 -0400 - 5 weeks ago

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Profound Medical Corp. - PROF

Apr 21, 2026, 7:00 AM EDT - 5 weeks ago

Profound Medical Slides: Corporate presentation

Tue, 14 Apr 2026 07:30:00 -0400 - 6 weeks ago

Profound Medical to Participate in the 2026 Bloom Burton & Co. Healthcare Investor Conference

Thu, 09 Apr 2026 09:00:00 -0400 - 7 weeks ago

Profound Medical Corp. Investigated by the Portnoy Law Firm

Wed, 01 Apr 2026 08:15:00 -0400 - 2 months ago

Incision-Free, MRI-Guided Prostate Treatment with Profound's TULSA-PRO® to be Featured in Multiple Presentations at the Upcoming 2026 Society of Interventional Radiology Scientific Meeting

Fri, 27 Mar 2026 07:45:00 -0400 - 2 months ago

Profound Medical Congratulates Texas Prostate on Achieving 100th TULSA Procedure™ Milestone

Fri, 20 Mar 2026 06:23:16 -0400 - 2 months ago

Top 3 Health Care Stocks That Are Set To Fly In March

2026-03-13T16:26:46.000Z - 2 months ago

Profound Medical's (PROF) TULSA Procedure Shows Superior Safety Outcomes

Mar 13, 2026, 11:30 AM EDT - 2 months ago

Profound Medical Transcript: Status update

2026-03-13T14:40:28.000Z - 2 months ago

Profound Medical reports CAPTAIN trial meets primary safety endpoint

Fri, 13 Mar 2026 10:30:00 -0400 - 2 months ago

CAPTAIN Trial Comparing Profound's MRI-Guided TULSA Procedure™ to Robotic Radical Prostatectomy Successfully Meets Primary Safety Endpoint, Preservation of Erectile Function and Urinary Continence

2026-03-09T14:26:33.000Z - 3 months ago

Profound Medical (PROF) Awaits Key Clinical Data Presentation

2026-03-09T12:51:42.000Z - 3 months ago

Profound Medical pullback after Q4 report ‘misguided,’ says Lake Street

2026-03-05T21:59:47.000Z - 3 months ago

Profound Medical (PROF) Reports Q4 Revenue Below Expectations

2026-03-05T21:30:08.000Z - 3 months ago

Profound Medical Q4 Earnings Assessment

Mar 5, 2026, 4:30 PM EST - 3 months ago

Profound Medical Earnings Call Transcript: Q4 2025

Mar 5, 2026, 4:30 PM EST - 3 months ago

Profound Medical Annual report: Q4 2025

Mar 5, 2026, 4:30 PM EST - 3 months ago

Profound Medical Earnings release: Q4 2025

2026-03-05T21:27:53.000Z - 3 months ago

Profound Medical reports Q4 EPS (27c), consensus (28c)

2026-03-04T20:03:05.000Z - 3 months ago

Profound Medical's Earnings: A Preview

2026-03-04T12:22:47.000Z - 3 months ago

Profound Medical Corp (PROF) Q4 2025 Earnings Report Preview: What To Expect

2026-02-05T13:12:03.000Z - 4 months ago

Profound Medical, Pro Familia completed 500th Sonalleve Procedure

2026-01-15T12:36:14.000Z - 4 months ago

Profound Medical announces Mount Sinai Hospital treated patient with TULSA-PRO

2026-01-12T13:36:38.000Z - 5 months ago

Profound Medical surpasses 2025 TULSA-PRO installed base goal

2026-01-07T13:46:03.000Z - 5 months ago

Profound Medical price target raised to $12 from $11 at Lake Street

2026-01-06T12:50:20.000Z - 5 months ago

Profound Medical says Johns Hopkins treats first commercial TULSA-PRO case

Jan 6, 2026, 7:45 AM EST - 5 months ago

Johns Hopkins Medicine Treats First Commercial TULSA-PRO® Case

Dec 30, 2025, 4:30 PM EST - 5 months ago

Profound Medical Corp. Announces Closing of Private Placement

Dec 24, 2025, 1:15 PM EST - 5 months ago

Profound Medical Corp. Announces Upsize of Private Placement

Dec 23, 2025, 8:00 AM EST - 5 months ago

Profound Medical Corp. Closes $36 Million Registered Direct Offering; Expects to Complete Subsequent Private Placement On or Before December 30th

2025-12-19T13:50:40.000Z - 5 months ago

Profound Medical prices 5.14M shares at $7.00 in registered direct offering

Dec 19, 2025, 8:45 AM EST - 5 months ago

Profound Medical Corp. Announces Pricing of up to $40 Million Financing Comprised of a $36 Million Registered Direct Offering and a Subsequent $4 Million Private Placement

Dec 4, 2025, 5:00 PM EST - 6 months ago

Stanford Medicine's Dr. Pejman Ghanouni Receives RSNA's Cum Laude Award for CAPTAIN Perioperative Data Presentation

2025-11-28T12:50:06.000Z - 6 months ago

Profound Medical to launch AI-powered BPH module

Nov 28, 2025, 7:45 AM EST - 6 months ago

Profound Medical to Launch AI-Powered BPH Module, Present New TULSA-PRO® Clinical Data, at RSNA and SUO Meetings

Nov 25, 2025, 7:00 AM EST - 6 months ago

Profound Medical Slides: Investor presentation

Nov 18, 2025, 4:15 PM EST - 6 months ago

Profound Medical Celebrates The Hong Center's 200th Independent TULSA Procedure for Prostate Disease

2025-11-16T10:55:05.000Z - 7 months ago

Profound Medical reports Q3 EPS (26c), consensus (38c)

2025-11-16T10:31:21.000Z - 7 months ago

Profound Medical reports Q3 EPS (26c), consensus (38c)

2025-11-13T22:10:18.000Z - 7 months ago

Profound Medical files $150M mixed securities shelf

2025-11-13T21:46:00.000Z - 7 months ago

Profound Medical reports Q3 EPS (26c), consensus (38c)

Nov 13, 2025, 4:30 PM EST - 7 months ago

Profound Medical Earnings Call Transcript: Q3 2025

Nov 13, 2025, 4:30 PM EST - 7 months ago

Profound Medical Quarterly report: Q3 2025

Nov 13, 2025, 4:30 PM EST - 7 months ago

Profound Medical Earnings release: Q3 2025

Nov 13, 2025, 4:05 PM EST - 7 months ago

Profound Medical Reports Strong Third Quarter 2025 Financial Results

Nov 13, 2025, 7:00 AM EST - 7 months ago

Profound Medical Registration statement: Registration Filing

2025-11-12T15:45:31.000Z - 7 months ago

Profound Medical management to meet virtually with Lake Street

2025-11-12T13:40:36.000Z - 7 months ago

Profound Medical announces distribution agreement with Getz Healthcare

Nov 12, 2025, 8:30 AM EST - 7 months ago

Profound Medical Announces Strategic Distribution Agreement with Getz Healthcare to Bring TULSA-PRO® to Australia and New Zealand

Nov 11, 2025, 4:15 PM EST - 7 months ago

Profound Medical Inks Exclusive Distribution Agreement for TULSA-PRO® and Sonalleve® with Al Faisaliah Medical Systems in Saudi Arabia

Nov 11, 2025, 1:20 PM EST - 7 months ago

Profound Medical Transcript: Stifel 2025 Healthcare Conference

2025-11-10T22:10:17.000Z - 7 months ago

Profound Medical regains exclusive distribution rights for Tulsa-Pro in Canada

Oct 14, 2025, 8:30 AM EDT - 8 months ago

Profound Medical to Participate in the Stifel 2025 Healthcare Conference

Oct 7, 2025, 7:45 AM EDT - 8 months ago

Profound Medical Achieves Record Preliminary Unaudited Revenue for the 2025 Third Quarter

Sep 23, 2025, 8:00 AM EDT - 8 months ago

Texas Prostate and Dallas Medical Center Launch First-of-its-Kind TULSA Program, Expanding Access to Advanced Prostate Treatment

Aug 28, 2025, 8:00 AM EDT - 9 months ago

Profound Medical to Participate in Lake Street's 9th Annual Best Ideas Growth Conference

Aug 14, 2025, 4:30 PM EDT - 10 months ago

Profound Medical Earnings Call Transcript: Q2 2025

Aug 14, 2025, 4:30 PM EDT - 10 months ago

Profound Medical Earnings release: Q2 2025

Aug 14, 2025, 4:30 PM EDT - 10 months ago

Profound Medical Quarterly report: Q2 2025

Aug 14, 2025, 4:05 PM EDT - 10 months ago

Profound Medical Announces Second Quarter 2025 Financial Results

Jul 24, 2025, 5:00 PM EDT - 11 months ago

Profound Medical to Release Second Quarter 2025 Financial Results on August 14 – Conference Call to Follow

May 8, 2025, 4:30 PM EDT - 1 year ago

Profound Medical Earnings Call Transcript: Q1 2025

May 8, 2025, 4:30 PM EDT - 1 year ago

Profound Medical Earnings release: Q1 2025

May 8, 2025, 4:30 PM EDT - 1 year ago

Profound Medical Quarterly report: Q1 2025

May 3, 2025, 7:00 AM EDT - 1 year ago

Profound Medical Slides: Investor Presentation

Apr 30, 2025, 4:30 PM EDT - 1 year ago

Profound Medical to Participate in the 2025 Bloom Burton & Co. Healthcare Investor Conference

Apr 29, 2025, 7:30 AM EDT - 1 year ago

Initial Perioperative Data from CAPTAIN Randomized Trial Demonstrate MRI-Guided TULSA Provides Statistically Significant Improvement of Post-Operative Experience Vs. Robotic Radical Prostatectomy

Apr 28, 2025, 6:30 PM EDT - 1 year ago

Profound Medical Transcript: Status Update

Apr 28, 2025, 6:30 PM EDT - 1 year ago

Profound Medical Press release: Status Update

Apr 15, 2025, 7:45 AM EDT - 1 year ago

Profound Medical AUA 2025 Investor Event Agenda

Mar 6, 2025, 4:30 PM EST - 1 year ago

Profound Medical Earnings Call Transcript: Q4 2024

Mar 6, 2025, 4:30 PM EST - 1 year ago

Profound Medical Annual report: Q4 2024

Mar 6, 2025, 4:30 PM EST - 1 year ago

Profound Medical Earnings release: Q4 2024

Feb 13, 2025, 5:00 PM EST - 1 year ago

Profound Medical to Release Fourth Quarter and Full Year 2024 Financial Results on March 6 – Conference Call to Follow

Jan 8, 2025, 7:30 AM EST - 1 year ago

Profound Medical Announces Preliminary Unaudited Fourth Quarter and Full Year 2024 Revenues

BioTuesdays May. 28 at 1:49 PM

0 · Reply

alexpitti May. 27 at 1:38 AM

med tech is historically cheap $SI $STXS $PROF $DCTH

0 · Reply

Doozio May. 21 at 1:22 AM

Chop chop huckleberries $PROF Then ONTO 🐒🍌🧠⏰♾️

1 · Reply

NVDAMillionaire May. 19 at 9:29 PM

0 · Reply

BioTuesdays May. 15 at 3:15 PM

0 · Reply

CHItraders May. 15 at 11:35 AM

1 · Reply

alexpitti May. 14 at 4:03 PM

$PROF met with ceo again! arun is a great guy

1 · Reply

newsfile_corp May. 14 at 12:42 AM

https://nfne.ws/297432 $PROF $PRN.TSX @profound-medical-inc #Chemicals #Pharmaceutical #HealthCare #Medical #Pharmaceuticals #AGM #AnnualGe

0 · Reply

OfficialStocktwitsUser May. 13 at 4:59 AM

0 · Reply

MarketBeat May. 8 at 9:09 PM

Profound Medical Q1 Earnings Call Highlights $PROF https://www.marketbeat.com/instant-alerts/profound-medical-q1-earnings-call-highlights-2

0 · Reply

alexpitti May. 8 at 1:47 PM

$PROF how do you lower guidance completely and have your stock spike

1 · Reply

alexpitti May. 7 at 8:46 PM

$PROF ugly guidance

1 · Reply

StocktwitsEarnings May. 7 at 8:28 PM

$PROF Q1 '26 Earnings Results & Recap • Reported GAAP EPS of $0.19 down -47.22% YoY • Reported revenue of $5.34M up 103.62% YoY • Profound Medical Corp. projects total revenue for full-year 2026 to be approximately $25M, representing 56% growth, and expects full year 2026 gross margin to be 70% or higher.

1 · Reply

alexpitti May. 1 at 4:50 AM

$PROF profound is listed as experimental in nccn guidelines and needs 3 years of cancer data to change that

1 · Reply

SuperGreenToday Apr. 23 at 12:34 PM

$PROF Share Price: $6.95 Contract Selected: Oct 16, 2026 $10 Calls Buy Zone: $0.46 – $0.57 Target Zone: $0.76 – $0.93 Potential Upside: 56% ROI Time to Expiration: 175 Days | Updates via https://fxcapta.com/stockinfo/

0 · Reply

alexpitti Apr. 20 at 8:18 PM

$PROF why is this stock rallying so much

1 · Reply

PantySniffer69420 Apr. 20 at 6:46 PM

$PROF I’m out. Gap filled at 7.11

0 · Reply

BioTuesdays Apr. 14 at 7:53 PM

$PROF The Society of Interventional Radiology (SIR) has highlighted the results of Profound Medical’s (NASDAQ: PROF; TSX: PRN) randomized post-market CAPTAIN trial demonstrating that men with localized, intermediate-risk prostate cancer recovered faster and experienced less short-term impact on their daily lives when treated with MRI-guided, transurethral ultrasound ablation (TULSA) compared with robotic prostatectomy (RP). https://biotuesdays.com/2026/04/14/sir-highlights-profounds-captain-study-results-showing-faster-recovery-with-tulsa-v-robotic-prostate-surgery/

0 · Reply

prismmarketview Apr. 7 at 3:15 PM

PRISM Men’s Health Spotlight We’re adding @ProfoundMedical (Nasdaq: $PROF) to the PRISM MedTech Index. Profound is advancing an incision-free approach to prostate disease with its TULSA-PRO system, combining MRI guidance and AI-powered ultrasound ablation to precisely target tissue while preserving key functions such as continence and erectile function. Recent updates point to strong commercial momentum, record revenue growth, and encouraging clinical data from the CAPTAIN trial. A differentiated platform in a large and evolving category within men’s health. Welcome to the index, $PROF. #ProfoundMedical #UltrasoundAblation https://prismmarketview.com/companies/profound-medical-corp/

0 · Reply

PantySniffer69420 Mar. 31 at 5:56 PM

$PROF

0 · Reply

alexpitti Mar. 30 at 9:25 PM

guys follow me. i'm back on twitter $DCTH $STXS $RCEL $ABEO $PROF https://x.com/alex__pitti

0 · Reply

johntarlick Mar. 28 at 10:41 AM

$PROF well that's now the 2nd time a news item related to texas prostate has bumped the price substantially, even though texas prostate isn't doing anything different than any other tulsa treatment provider of the past 6 years has done, and continues to do. wish i knew what the markets evidently know.

1 · Reply

Market Cap	247.46M
Revenue (ttm)	16.10M
Net Income (ttm)	-42.57M
EPS (ttm)	N/A
PE Ratio	0.00
Forward PE	N/A
Profit Margin	-264.41%
Debt to Equity Ratio	0.08

Volume	28,200
Avg Vol	131,298
Day's Range	N/A - N/A
Shares Out	36.34M
Stochastic %K	39%
Beta	0.73
Analysts	Strong Sell
Price Target	$11.12